Quantcast
Last updated on April 21, 2014 at 5:04 EDT

Latest Trichomonas vaginalis Stories

2014-02-25 04:21:57

A year of significant progress BATH, England, February 25, 2014 /PRNewswire/ -- Atlas Genetics Ltd ("Atlas" or the "Company"), developer of innovative, ultra-rapid diagnostics to enable a 'test and treat' solution to infectious diseases, today announces its Annual Summary for 2013. - Successful clinical evaluations of our Gonorrhoea and Trichomonas vaginalis tests add to the existing clinical data for the Chlamydia test - Menu development...

2013-08-27 08:27:40

New Molecular Test Available to Diagnose Trichomonas vaginalis in Asymptomatic and Symptomatic Females BALTIMORE, Aug. 27, 2013 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the U.S. Food and Drug Administration clearance and launch of the BD ProbeTec(TM) Trichomonas vaginalis Q(x) Amplified DNA Assay for the direct qualitative detection of T. vaginalis DNA in endocervical and...

2013-01-14 02:29:20

BEDFORD, Mass., Jan. 14, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the U.S. Food and Drug Administration (FDA) has cleared for marketing its APTIMA Trichomonas vaginalis Assay on the Company's fully-automated PANTHER System. The APTIMA Trichomonas vaginalis Assay, first...

2012-11-08 12:28:38

Researchers find a viral symbiont of a protozoan parasite increases virulence to the human host When humans have parasites, the organisms live in our bodies, co-opt our resources and cause disease. However, it turns out that parasites themselves can have their own co-habitants. Researchers from Harvard Medical School, Brigham and Women's Hospital and SUNY Upstate Medical University have found that the pathogenicity of the sexually transmitted protozoan parasite Trichomonas...

2012-04-02 02:27:50

HAMILTON, N.J., April 2, 2012 /PRNewswire/ -- Medical Diagnostic Laboratories, L.L.C. (MDL) is a CLIA certified infectious disease laboratory which specializes in high-complexity, state-of-the-art, automated DNA-based molecular analyses. By using molecular techniques, MDL is able to provide clinicians from many different specialties valuable tailored diagnostic information to assist in the detection, diagnosis, evaluation, and treatment of viral, fungal, and bacterial infections. MDL, a...

2011-07-13 15:01:00

SAN DIEGO, July 13, 2011 /PRNewswire/ -- Two new studies presented this week at a leading infectious disease meeting demonstrate that sexually transmitted disease (STD) caused by the parasite Trichomonas vaginalis is more common than previously thought, especially in women over 40, and that a recently cleared molecular test can help improve detection of the often overlooked but potentially serious infection. "This new research shows that Trichomonas is an important public health issue,...

2011-07-12 12:41:29

Johns Hopkins expert calls for testing and mandatory reporting A Johns Hopkins infectious disease expert is calling for all sexually active American women age 40 and older to get tested for the parasite Trichomonas vaginalis after new study evidence found that the sexually transmitted disease (STD) is more than twice as common in this age group than previously thought. Screening is especially important because in many cases there are no symptoms. "We usually think of STDs as more prevalent in...

2011-04-20 06:30:00

SAN DIEGO, April 20, 2011 /PRNewswire/ -- Gen-Probe Incorporated (NASDAQ: GPRO) announced today that the US Food and Drug Administration (FDA) has cleared for marketing its APTIMA® Trichomonas vaginalis assay on the fully automated TIGRIS® system. The APTIMA assay is the first amplified nucleic acid test specifically cleared to detect Trichomonas vaginalis, the most common curable sexually transmitted infection in the United States. The assay may be...

2011-03-09 13:39:18

First-of-its-kind study from Rhode Island Hospital also finds older age group A study from the microbiology lab at Rhode Island Hospital has found that a new test may be more accurate in identifying a common sexually transmitted infection (STI), Trichamonos vaginalis (TV). The researchers also noted a high prevalence of TV in women in the 36- to 45- year-old age group -- a group not normally included in the recommended STI screening criteria. The study is now published online in advance of...

2010-10-04 15:00:00

SAN DIEGO, Oct. 4 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its APTIMA® Trichomonas vaginalis assay on the fully automated TIGRIS® system. "Trichomonas is the most common curable sexually transmitted disease in young women, and it can lead to serious health consequences if left untreated," said Carl Hull, Gen-Probe's...